Kura Oncology, Inc. (KURA)

Kura Oncology Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	1,568	1,068	830	932	1,852	623
Market Cap Growth	94.03%	28.65%	-10.90%	-49.69%	197.25%	16.67%
Enterprise Value	1,058	661	406	420	1,231	394
PE Ratio	-	-7.00	-6.11	-7.14	-20.66	-9.87
PB Ratio	3.10	2.69	1.98	1.84	3.03	2.85
P/FCF Ratio	-11.77	-8.54	-7.50	-8.82	-25.72	-11.38
P/OCF Ratio	-11.79	-8.56	-7.54	-8.91	-26.52	-11.38
EV/EBITDA Ratio	-6.73	-4.40	-3.01	-3.25	-13.86	-6.29
EV/EBIT Ratio	-6.69	-4.38	-3.00	-3.23	-13.83	-6.29
EV/FCF Ratio	-8.07	-5.29	-3.67	-3.98	-17.10	-7.19
Debt / Equity Ratio	0.03	0.04	0.03	0.01	0.02	0.03
Debt / EBITDA Ratio	-0.10	-0.11	-0.10	-0.05	-0.15	-0.12
Debt / FCF Ratio	-0.12	-0.14	-0.13	-0.07	-0.18	-0.14
Quick Ratio	16.34	12.02	18.21	23.08	24.34	15.22
Current Ratio	16.67	12.26	18.56	23.26	24.49	15.40
Interest Coverage	-105.18	-97.54	-592.19	-314.14	-154.06	-107.86
Return on Equity (ROE)	-37.50%	-36.30%	-30.80%	-23.90%	-24.80%	-29.80%
Return on Assets (ROA)	-34.10%	-33.10%	-29.00%	-22.70%	-22.90%	-27.10%
Return on Capital (ROIC)	-35.19%	-40.00%	-32.20%	-25.56%	-14.73%	-29.82%
Earnings Yield	-10.72%	-14.29%	-16.36%	-14.00%	-4.84%	-10.13%
FCF Yield	-8.80%	-11.70%	-13.33%	-11.34%	-3.89%	-8.79%
Buyback Yield / Dilution	-22.66%	-9.31%	-0.96%	-25.01%	-26.54%	-19.20%
Total Shareholder Return	-22.66%	-9.31%	-0.96%	-25.01%	-26.54%	-19.20%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).